文献速递儿科与产科急症重症综合管理与镇静镇痛

经鼻右美托咪定喷雾与滴剂对儿科静脉穿刺反应镇静效果的比较

Sedation effects of intranasal dexmedetomidine delivered as sprays versus drops on pediatric response to venous cannulation.
PubMed 文献 · Am J Emerg Med · 2017-03-18
一句话结论2–5岁择期眼科手术患儿经鼻给予右美托咪定2μg/kg时,喷雾较滴剂能更降低静脉穿刺时的FLACC评分,心率下降与呼吸抑制均无需临床干预。

本研究纳入106例2–5岁择期眼科手术患儿,随机分为注射器滴剂组与黏膜雾化装置(MAD)喷雾组,经鼻给予右美托咪定2μg/kg(容积20μl/kg)用于镇静以减轻静脉穿刺反应。主要终点为给药30分钟后外周静脉穿刺的FLACC评分。结果显示MAD组FLACC评分显著低于滴剂组(P=0.021);两组经鼻给药接受度、镇静起效时间及需两次及以上穿刺的发生率均无显著差异(均P>0.05)。两组均无因心率下降需临床干预者,也无呼吸抑制发生。

要点

  • 2–5岁择期眼科手术患儿经鼻右美托咪定2μg/kg(20μl/kg)时,MAD喷雾组静脉穿刺FLACC评分显著低于注射器滴剂组(P=0.021)。
  • 两组经鼻给药接受度相当(P>0.05),喷雾并未降低患儿对经鼻给药的接受度。
  • 两组镇静起效时间及需两次及以上穿刺的发生率无显著差异(均P>0.05)。
  • 两组均无因心率下降需临床干预者,也无呼吸抑制发生。

适用人群与场景

  • 2–5岁择期眼科手术患儿,术前等候区经鼻给予右美托咪定镇静以减轻静脉穿刺反应。

处置流程与药物剂量

  • 经鼻给予右美托咪定2μg/kg,容积20μl/kg;滴剂组用注射器滴入,喷雾组用黏膜雾化装置(MAD)喷入。
  • 给药30分钟后评估外周静脉穿刺的FLACC评分(faces、legs、activity、cry、consolability)。

研究设计与关键结果

  • 随机对照研究,106例2–5岁择期眼科手术患儿,随机分为注射器滴剂组与MAD喷雾组,经鼻给予右美托咪定2μg/kg(20μl/kg)。
  • 主要终点:给药30分钟后静脉穿刺FLACC评分,MAD喷雾组显著低于滴剂组(P=0.021)。
  • 次要终点:两组经鼻给药接受度相当(P>0.05);镇静起效时间及需两次及以上穿刺的发生率均无显著差异(均P>0.05)。
  • 不良事件:两组均无因心率下降需临床干预者,也无呼吸抑制发生。

证据类型、等级与局限

  • 研究类型:随机对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,经鼻右美托咪定喷雾较滴剂能提供更好的镇静效果以减轻静脉穿刺反应。
  • 2–5岁择期眼科手术患儿经鼻右美托咪定2μg/kg镇静时,喷雾与滴剂在给药接受度、起效时间及需重复穿刺率上无显著差异,两组均无因心率下降需临床干预及无呼吸抑制。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Mucosal atomization device (MAD) was designed to increase the bioavailability of intranasal medications by facilitating absorption, the present study aimed to evaluate and compare the sedation effects of intranasal dexmedetomidine delivered as drops versus sprays on pediatric responses to intravenous cannulation.

METHODS: One hundred and six pediatric patients (aged from 2 to 5years) scheduled for elective ophthalmic surgery were intranasally received a dose of 2μg/kg in 20μl/kg of dexmedetomidine for sedation to reduce response to venous cannulation. The patients were randomized into syringe group and MAD group in which dexmedetomidine was delivered as drops or sprays via syringe or MAD respectively. The primary outcome was the response to peripheral vein cannulation assessed by the FLACC scores (faces, legs, activity, cry and consolability) 30min after intranasal administration of dexmedetomidine. The secondary outcomes included acceptance for intranasal medication, sedation onset time, and needle insertion times and any adverse event at the preoperative holding area.

RESULTS: The FLACC scores in MAD group were significantly decreased than that treated by drops (P=0.021). The acceptance for intranasal administration between both groups was comparable (P>0.05), the onset time and the incidences in two and more times of needle insertion did not differ significantly between syringe and MAD groups (all P>0.05). None of patients were required to clinically intervene in heart rates reduction and none suffered respiratory depression after administrations of dexmedetomidine in either group.

CONCLUSION: Intranasal dexmedetomidine by sprays offers better sedation effects to reduce responses to venous cannulation than drops.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Xie Z, Shen W, Lin J, et al. Sedation effects of intranasal dexmedetomidine delivered as sprays versus drops on pediatric response to venous cannulation. Am J Emerg Med. 2017. PMID: 28347608. doi:10.1016/j.ajem.2017.03.021

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。